Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have a reliable hypoglycaemic and weight-loss effect that can intervene in obesity, which is the basis of type 2 diabetes pathology
New pricing for new accounts only effective as of March 31, 2026
Glatter: Additional approaches to lose weight and manage cardiometabolic aspects of obesity include adherence to the Mediterranean, DASH, or MIND diet, along with adequate strength training, close monitoring of hydration status, and caloric intake to maintain and prevent muscle loss, particularly while taking a GLP-1
Whether youre using a GLP-1 or pursuing lifestyle-based weight loss alone, the goal is the same: Construct a way of eating (and a way of living) that supports both your health and weight loss maintenance long-term
So when in that space its like, wait a second
These experiments established central GLP-1 as a physiological regulator of food intake maintaining an inhibitory tonus